Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project
Top Cited Papers
- 1 August 2009
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 10 (8), 816-824
- https://doi.org/10.1016/s1470-2045(09)70161-5
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports projectBlood, 2009
- Detection of JC Virus DNA and Proteins in the Bone Marrow of HIV‐Positive and HIV‐Negative Patients: Implications for Viral Latency and Neurotropic TransformationThe Journal of Infectious Diseases, 2009
- Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte functionNeurology, 2009
- The role of polyomaviruses in human diseaseVirology, 2008
- Detection of JC virus DNA fragments but not proteins in normal brain tissueAnnals of Neurology, 2008
- Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumabBlood, 2008
- Therapeutic B cell depletion impairs adaptive and autoreactive CD4+T cell activation in miceProceedings of the National Academy of Sciences, 2007
- Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2AVirology, 2007
- B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of responseAnnals Of The Rheumatic Diseases, 2007
- Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patientsJournal of Neuroimmunology, 2006